Canada's rare disease (RD) landscape is ripe for transformation, and the key to unlocking this potential lies in the power of data infrastructure. While the country has made significant strides in developing innovative programs and infrastructure, the current fragmentation and short-term funding cycles hinder progress. It's time for Canada to embrace a national vision and sustained investment to create a more integrated and equitable system for managing RDs.
One of the critical challenges in RD diagnosis is the need for accurate data sharing. The past 15 years have revolutionized clinical diagnosis through genomic DNA sequencing, but interpreting DNA variants requires access to large-scale datasets. This is where the All for One Data Sharing Agreement comes into play, enabling responsible sharing of clinically generated genomic and health data between diagnostic laboratories. However, this is just the beginning. Canada must recognize data sharing as core diagnostic infrastructure, not an optional add-on. When genomic testing is funded, the costs of responsible data sharing, interoperability, and legal/data governance support should be built into the model.
Another crucial aspect is the need for discovery research. Many patients harbor variants in genes not yet definitively linked to disease, and ongoing research is essential to bridge this gap. Initiatives like Care4Rare, which analyzes genomic data to identify new disease-gene relationships, are vital. On a national scale, the Pan-Canadian Genome Library acts as a centralized resource for responsible storage and sharing of Canadian genomic data, making these datasets more accessible for future RD research.
However, Canada's current approach is not enough. A learning health system cannot depend indefinitely on research projects with time-limited funding or voluntary alignment among already stretched clinical institutions. A federated approach may be the solution: data can remain within trusted institutions and jurisdictions while becoming discoverable, comparable, and usable through shared standards, governance, and infrastructure. This aligns with Canada's Expert Advisory Group on the Pan-Canadian Health Data Strategy, which calls for stronger health data foundations, including federated governance, interoperability, supportive policy, and public engagement.
To make responsible data sharing routine, Canada needs four shifts. First, federal leadership for genomic data sharing is essential. Without top-down mandates or strong national coordination, data sharing will remain uneven. Canada should follow in the footsteps of countries like England, Australia, and Denmark, which have created national strategies or government bodies for genomic medicine and health data infrastructure. Second, data sharing must be recognized and funded as core diagnostic infrastructure. Third, Canada must establish national standards for RD testing and data, including clear, pan-Canadian requirements for publicly funded genomic testing and standardized collection of phenotype, genotype, variant interpretation, consent, and outcomes data. Finally, patients, families, and communities must be partners in governance, ensuring that data sharing is purposeful, transparent, secure, reciprocal, and aligned with patient and community priorities.
In conclusion, Canada has the potential to create a more integrated and effective system for managing RDs. By embracing a national vision, sustained investment, and coordinated infrastructure, the country can transform a collection of local successes into a more integrated, equitable, and efficient system for persons living with RDs. Every test, every unsolved case, every diagnosis, and every patient experience can help strengthen the system for the next person. But this will only happen if data sharing is treated as core health infrastructure, supported by sustained investment, policy alignment, and coordination across jurisdictions and sectors.
